As state universities feel economic pinches of reduced support from state legislatures, and as sources of federal funding for supported research projects face additional challenges, other sources of support need to be found. Two sources under consideration are royalties and licensing fees for successful patents. A good example of a successful developer of patents was Jonas Kamlet, Ph.D. (1914Ph.D. ( -1960, who was an early consultant in chemical and other matters and was the successful co-owner, with his wife Edna, of the Kamlet Laboratories. The roles that he played in his career can, we believe, provide good examples for contemporary researchers in doing applied research and obtaining fees for consulting and related professional activities. We review here some of the pertinent roles in the life of Dr. Jonas Kamlet, which may serve as a guide for contemporary innovators.
INTRODUCTION
There has been significant concern recently over funding at colleges and universities. This may be especially true at state universities where the percentage of state support has steadily diminished or changed in basis of support. As Holbrook and Sanberg note, license and royalty income is one of the revenue sources that supports university research (1) , but the extent of the support from these sources has room for growth. In addition, many positive benefits, intrinsic and financial, have been considered (5) .
One possibility for enhancement is to accept the suggestion that patents be considered as part of tenure and promotion guidelines (10) . Another possibility is to study the success of others. Our favorite choice is an early consultant, Jonas Kamlet, and we note his efforts to sustain the Kamlet Laboratories in this article. We should recall his wisdom that a patent needs to be promoted or sold to be really successful.
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MARTIN AND THOMPSON
Jonas Kamlet was trained as a chemist and worked as a clinical chemist in the Israel Zion Hospital in Brooklyn, NY, where he gained considerable experience. He became an early self-supporting consultant in chemistry and developer of patents in his role as head of the Kamlet Laboratories that he and his wife established in 1941. The background of the Laboratories was reviewed in a previ0us article describing its development in the first 7 years, and it was estimated that the net cumulative value in 2011 dollars was about $750,000 (6) . After Kamlet's death, his widow Edna Yadven Kamlet continued the operation of the Laboratories until her retirement (7) .
USF was able to obtain the papers associated with the Kamlet Laboratories through a gift from his widow that supported transport of the papers to Tampa, FL, and a donation to cover the archiving process as described previously (6) .
Jonas Kamlet was a prolific inventor, though it is difficult to appreciate how truly inventive he was. Although some 106 patents are listed by SciFinder@, as we have noted elsewhere, the number is misleading because some entries were duplicates appearing as British patents as well as a Canadian and a French patent (8) . The total number of US patents seems to be 81, covering a period from March 22, 1938 (when he was about 24) to November 17, 1964 (about 4 years after his tragic death in an airplane disaster).
During the course of his impressive career,. Kamlet played many roles, and we believe that examining these roles provides a good example for persons who are concerned with patents and innovative processes. Jonas Kamlet realized that having patents could be a moneymaking-source but that the role of a salesman was a key to success.
In examining his career, it is evident that Kamlet was a man of many talents, but he was also a man of many Toles, and in this time of change, we believe. his life provides good lessons, and some of these are reviewed in the present article.
MATERIALS AND METHODS
Material contained in the USF Tampa Campus Special Collections was reviewed through the webpage for the Kamlet Papers (2). Files in individual b~xes were requested, reviewed, and pertinent letters were copied and saved as pdf files (Jonas & Edna KamletlKamlet Laboratories Records 1913-1989, Special Collections, University of South Florida).
RESULTS AND DISCUSSION
We have reviewed the background and found examples of activities that seem to fit a series of professional r9les.
Salesman
Perhaps first and foremost, Jonas Kamlet had to be a salesman. He needed to convince persons to retain his services until his reputation was sufficiently developed, and he needed to sell his patents, either after the initial declaration when he could transfer the rights and save patenting costs, or later when he could license the patents and recoup the costs. Jonas Kamlet was a man whose several traits and roles led to the success of the Kamlet Laboratories, a largely two-person operation, with others who were retained evidently on an as-needed basis, and whose efforts were 'coordinated by his wife, Edna. We think he is to be admired for several reasons, but certainly an important one is his role as a bench chemist, that is, a 9hemist who was at home next to a laboratory bench where pe was comfortable doing inorganic or organic syntheses, doing physical measurements, or analytical chemistry.
.
Scientific Literature Expert
Good patent applications and good consulting ideas demand an excellent grasp of the pertinent literature. Jonas Kamlet and his wife, Edna Yadven Kamlet, were avid readers of Chemical Abstracts, which they tended to split up. He covered the chemistry sections, and she, because of her biology major, covered the biological sections. Some examples of his range of expertise follow.
Example 1.
Asked to provide information on the production of hydroquinone, he noted difficulties in providing accurate statistics. The number of companies (names given) fell from five in 1949 to two by 1952. Kamlet candidly noted that his information was "scuttlebutt," that is, gathered from conversations and phone calls. He also provided the requested-data: year, production (pounds), sales (pounds), and value of the sales, all for the 3-year period 1946-1949. He noted that no published data had been available since 1948, but he was relying on information from a chemical broker. The data were for the photographic industry (for "hypo"), and an upper limit of the amount was provided for photographic and technical material.
Unfortunately, he had to note that he was unable achieve "even a crack" in die rubber industry armor of silence, owing to a common reply of "Sorry, restricted information" 
Patent Purveyor
Kamlet would develop a patent, then work with a company to arrange for payment of fees in return for assignment of the patent to the company and probably some concessions. A prime example was the development of a colorimetric pill for analysis of glucose. When looking for a source of stirring, he~eeded something to make the mixture effervesce. His wife suggested that he contact Miles Laboratories, developer of Alka-Seltzer, at least according to according to one account (7) .
A different version of the collaboration was found and reported, but the key aspect is the collaboration between Jonas Kamlet and Miles Laboratories "house expert on efflorescent," Mr. Maurice Treneer. The product of the collaboration was a pill called Clinitest that would react with a sample, and the color developed could be used to estimate the amount of glucose present. It was a rapid test that could be performed in a physician's office to test diabetic patients and had a sales lifetime of about 40 years. It was replaced by another Miles product, Clinistix (9) .
In fairness, Kamlet was not always successful. There were no patents assigned to DuPont, though the opportunity was provided at least twice. For example, he noted that in a meeting at DuPont, he described "our work on the use of waste newsprint as a low-cost source of rough and digestible cellulose in such ruminate fodder. This work is covered by a patent application, now pending. We are enclosing herewith a copy of this patent application, entitled 'fodder fo~ruminants,' for your perusal" (Jonas & Edna Kamlet/Kamlet Laboratories Records 1913-1989;Special Collections, University of South Florida).
For whatever reasons, DuPont representatives did not choose to pursue this great idea, and a patent (US 2,715,067) was awarded August 9, 1955, but was not assigned to DuPont or any other firm. The idea, however, was sound and well tested on cattle (8).
Sales Representative
As noted elsewhere, Kamlet was on a consulting trip to the International Paper Company in Glenn Falls, N~and he suggested that there were a couple of problems that could be solved using the Clinitest kit. On a second trip, he brought along a kit and wrote to Dr. Raymond Conklin that he had been unable to find a pharmacy in Glenn Falls that stocked the kit, so he suggested that a half dozen complimentary kits be sent to a Dr. Taylor at International Paper (9).
Synthesizer
Jonas Kaf!llet was a superior organic chemist as indicated by the creativity and thoroughness of some of his patents. Example 1. Kamlet devised a synthesis of riboflavin (a.k.a. vitamin B2).1t eliminated steps in the contemporary synthesis, and it also obviated the use of the difficult-to-obtain and expensive pentose sugar D-ribose. The scope and details of each step are thoroughly described. The discovery of riboflavin and the identity as vitamin B2 had been reported only 10 years before the submission of his patent (4). Example 2. Jonas Kamlet was 24 years old when he was awarded his first patent for a synthesis of sulphanilamide. Offering some remarkable cures obtained in its use in the treatment of gonorrhea, this was surely a miracle drug for its time. He reported obtaining the desired product "in an exceptionally pure state and in quantitative yield by submitting benzamide-psulfonamide to a Hoffman reaction" (3).
Bench Chemist
A representative of American Home Products requested the development of a product similar to "SOILAX." Kamlet (Jonas & Edna Kamlet/Kamlet Laboratories Records 1913-1989, Special Collections, University of South Florida) purchased six boxes of the product from six different stores and analyzed the content (98% trisodium phosphate decahydrate) and explained the variability. He developed a 1,000-pound batch procedure for a product of "good appearance and homogeneity" and also a 10-pound procedure. The product (after tumbling for a -suitable length of time) was free-flowing with no tendency to cake, was readily soluble in water (hot or cold), did not leave residue, and fluoresced. He sent a pound, composed of 0.085% of the product ( 
Behind-the-Scenes Man
Example 1. Jonas Kamlet realized that there was a need for publicity for the Clinitest products, and his ideas are outlined in a letter written to Dr. R. L. Conklin of Miles Laboratories (9) . "One of the next steps that I believe we ought to take in the introduction of our Clinitest series to the physicians and clinical pathologists of this country, is to publish a paper in one of the journals (e.g., the Journal of Laboratory and Clinical Medicine is my choice" (9 Example 2. J~nas Kamlet had recently learned from an unimpeachable source that the Shell Development Company had developed a . superior process for the production of phthalic anhydride. He was writing on behalf of George Gallowhur, president of Gallowhur Chemical Company, whose firm was a major consumer of dimethyl phthalate in the US. Mr. Gallowhur wanted to discuss "an arrangement for the purchase of all or a major part of [Shell's] present and/or production of phthalic anhydride and/ or dimethyl phthalate." He asked for an airmail response that would be referred directly to Mr. Gallowhur. Interestingly enough, he signed the letter as being from Miles Laboratories, Inc. 
Noncomplainer Example 1. The aSSOCIatIOnwith Miles
Laboratory lasted a numb~r of years and was a profitable association, though just how profitable is open to question. His widow told one of us (D.P.M.) before her death that a certain patent assigned to Miles Laboratories earned the couple $5 million in 5 years even though they had expected $17 million (8) . However, there is nothing in the Miles Laboratory correspondence that implies unhappiness on the part of Dr. Kamlet. "
Example 2. As noted elsewhere, Kamlet was asked to provide answers to 13 questions about each of 36 processes and chemicals in less than 7 days. He did so uncomplainingly. The response by Mr. Paul C. Jones noted that though Kamlet might feel an undue burden was laid on him, prior action by only one or two persons can save, for a much larger group, "an important amount of the only factor in business which is wholly irreplaceable, namely time" (8) . The uncomplaining and unselfish response may remind us that at some time we may be responsible for key actions.
WWII Draft Deferee
Though Jonas Kamlet was evidently an ablebodied person, married, and with no children; . "I trust your recent disposition has passed and that you are now among the quick. I think it was Cicero who said, 'Alexander magnus corpore parvus erat.' Though Alexander was a mighty man, his body was puny indeed. Since our intelleCt is inextricably housed in a most onerous and imperfect dwelling, I guess we must take these periods of illness with good grace. What cannot be endured must be survived."
A humorous side was also present, though not .seen often in the correspondence. In connection with the development of ice cream additives, he wrote, "I will bravely volunteer to personally taste the finished samples of ice-cream product. No sacrifice is too great for SCIENCE." SUMMARY Dr. Jonas Kamlet was a unique individual, and few are qualified to play the roles that he did, but he provides an example of dedication, of utilizing the resources available to him, and of recognition of his worth and value.
Dedication to our individual professions and support of creativity and innovation are characteristics that are within our grasps.
Finally, and perhaps most importantly, we can emulate Kamlet's attitude toward failure. At one point, he was asked about times that he had been "scooped," that is, good ideas that for one reason did not come to fruition, despite being good or covered by patents (Jonas & Edna KamletiKamlet Laboratories Record's 1913-1989, Special Collections, University of South Florida). He responded with some 23 that he could document with respect to time of concept. (At the time, most of his successes were ahead of him.) He also noted that every research organization had its morgue of failed ideas and concluded, "It is all in the Game. It's the Future that concerns us, not the Past."
